© 2022 MJH Life Sciences and Contagion Live. All rights reserved.
© 2022 MJH Life Sciences™ and Contagion Live. All rights reserved.
December 13, 2021
Recent study results show promising new modalities.
April 21, 2021
This approach can help with clinical outcomes and mortality, but resistance is not as well defined.
February 18, 2019
Ceftazidime-avibactam is a novel treatment for CRE infections, but reports of resistance are increasing.
Monkeypox Symptoms in London Patients Differ from Prior Outbreaks
How COVID-19 Infiltrates and Inflames the Heart
Top 5 Infectious Disease Stories of the Week: July 1, 2022
Communities With More Racial Prejudice Have Worse Health Outcomes